WASHINGTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided an update on its application to list on the Johannesburg Stock Exchange (“JSE”).
Related Questions
Could the dual listing create arbitrage opportunities for traders between the two markets?
What is the expected timeline for the JSE listing to become fully operational and reflected in market data?
Will the dual listing lead to any changes in the company's dividend policy or share buyback plans?
What price differential can be expected between the NASDAQ and JSE listings?
How does this listing strategy compare to competitors in the advanced materials and isotope sector?
Will the JSE listing attract new institutional investors or increase the company's market capitalization?
What are the potential regulatory and compliance costs associated with maintaining a listing on both NASDAQ and JSE?
Could the JSE listing expose ASP Isotopes to currency risk and how will that be managed?
How might the dual listing impact the company's valuation multiples compared to peers listed only on US exchanges?
How will the dual listing on the JSE affect ASP Isotopes' share liquidity and trading volume?